{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:36:05Z","timestamp":1793262965578,"version":"4.5.0"},"reference-count":4,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jiac.2026.103095","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:50:14Z","timestamp":1790981414000},"page":"103095","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Blood culture before empiric piperacillin\/tazobactam: From process measurement to clinical utility"],"prefix":"10.1016","volume":"32","author":[{"given":"\u015eeyma Nur Uysal","family":"Karata\u015f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5640-9196","authenticated-orcid":false,"given":"Eren","family":"\u00c7a\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jiac.2026.103095_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiac.2026.103033","article-title":"Blood culture collection practice prior to empiric piperacillin\/tazobactam in patients requiring hospitalization: a potential target for antimicrobial stewardship from a single-center retrospective observational study","volume":"32","author":"Kitaura","year":"2026","journal-title":"J Infect Chemother"},{"issue":"3","key":"10.1016\/j.jiac.2026.103095_bib2","doi-asserted-by":"crossref","first-page":"e01005","DOI":"10.1128\/jcm.01005-21","article-title":"Blood culture utilization in the hospital setting: a call for diagnostic stewardship","volume":"60","author":"Fabre","year":"2022","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiac.2026.103095_bib3","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jiac.2026.103095_bib4","unstructured":"Centers for Disease Control and Prevention. Collect adult blood culture sets. Laboratory Quality. Updated March 31, 2026. Accessed August 31, 2026. https:\/\/www.cdc.gov\/lab-quality\/php\/preventing-adult-blood-culture-contamination\/collect.html."}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26001935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26001935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:12:19Z","timestamp":1793261539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X26001935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":4,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1341321X26001935"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2026.103095","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood culture before empiric piperacillin\/tazobactam: From process measurement to clinical utility","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2026.103095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103095"}}